General Information of Drug Off-Target (DOT) (ID: OTR61MI8)

DOT Name Kappa-casein (CSN3)
Gene Name CSN3
Related Disease
Carcinoma ( )
Multiple sclerosis ( )
Bone osteosarcoma ( )
Cardiovascular disease ( )
Hepatocellular carcinoma ( )
Liver cirrhosis ( )
Neoplasm ( )
Osteosarcoma ( )
Ankylosing spondylitis ( )
Undifferentiated carcinoma ( )
Fish eye disease ( )
UniProt ID
CASK_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00997
Sequence
MKSFLLVVNALALTLPFLAVEVQNQKQPACHENDERPFYQKTAPYVPMYYVPNSYPYYGT
NLYQRRPAIAINNPYVPRTYYANPAVVRPHAQIPQRQYLPNSHPPTVVRRPNLHPSFIAI
PPKKIQDKIIIPTINTIATVEPTPAPATEPTVDSVVTPEAFSESIITSTPETTTVAVTPP
TA
Function Kappa-casein stabilizes micelle formation, preventing casein precipitation in milk.
Tissue Specificity Mammary gland specific. Secreted in milk.
Reactome Pathway
Miscellaneous transport and binding events (R-HSA-5223345 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Carcinoma DISH9F1N Definitive Biomarker [1]
Multiple sclerosis DISB2WZI Definitive Altered Expression [2]
Bone osteosarcoma DIST1004 Strong Biomarker [3]
Cardiovascular disease DIS2IQDX Strong Genetic Variation [4]
Hepatocellular carcinoma DIS0J828 Strong Altered Expression [3]
Liver cirrhosis DIS4G1GX Strong Altered Expression [3]
Neoplasm DISZKGEW Strong Altered Expression [3]
Osteosarcoma DISLQ7E2 Strong Biomarker [3]
Ankylosing spondylitis DISRC6IR moderate Biomarker [5]
Undifferentiated carcinoma DISIAZST Disputed Biomarker [1]
Fish eye disease DISYTZNQ Limited Biomarker [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Kappa-casein (CSN3). [7]
Permethrin DMZ0Q1G Approved Permethrin decreases the expression of Kappa-casein (CSN3). [8]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Kappa-casein (CSN3). [9]
------------------------------------------------------------------------------------

References

1 Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.Toxicol Pathol. 2005;33(7):768-75. doi: 10.1080/01926230500437027.
2 Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis.J Immunol. 2007 Sep 15;179(6):4074-82. doi: 10.4049/jimmunol.179.6.4074.
3 Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.Cancer Chemother Pharmacol. 2012 May;69(5):1173-80. doi: 10.1007/s00280-011-1810-x. Epub 2012 Jan 12.
4 Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease.Pflugers Arch. 2010 Jul;460(2):343-51. doi: 10.1007/s00424-009-0768-6. Epub 2009 Dec 31.
5 Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients.J Immunol. 1986 Oct 1;137(7):2168-72.
6 Tumor-protective and tumor-promoting actions of dietary whey proteins in an N-methyl-N-nitrosourea model of rat mammary carcinogenesis.Nutr Cancer. 2006;55(2):171-7. doi: 10.1207/s15327914nc5502_8.
7 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
8 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.